|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 31/5365 | (2006.01) |
| A61K 31/505 | (2006.01) | ||
| A61P 31/18 | (2006.01) |
| (11) | Number of the document | 2932970 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15164931.6 |
| Date of filing the European patent application | 2011-01-24 | |
| (97) | Date of publication of the European application | 2015-10-21 |
| (45) | Date of publication and mention of the grant of the patent | 2018-03-21 |
| (46) | Date of publication of the claims translation | 2018-06-25 |
| (30) | Number | Date | Country code |
| 298589 P | 2010-01-27 | US |
| (72) |
Underwood, Mark Richard, US
|
| (73) |
VIIV Healthcare Company,
251 Little Falls Drive, Wilmington, DE 19808,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Antivirusinė terapija |
| ANTIVIRAL THERAPY |
| Payment date | Validity (years) | Amount | |
| 2023-12-19 | 14 | 289.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2023-12-18 |